Committee for Medicinal Products for Human Use
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
regulatory committee
|
| gptkbp:abbreviation |
gptkb:CHMP
|
| gptkbp:established |
2004
|
| gptkbp:givesOpinionOn |
efficacy of medicines
quality of medicines safety of medicines |
| https://www.w3.org/2000/01/rdf-schema#label |
Committee for Medicinal Products for Human Use
|
| gptkbp:jurisdiction |
gptkb:European_Union
|
| gptkbp:language |
English
|
| gptkbp:location |
gptkb:Amsterdam,_Netherlands
|
| gptkbp:parentOrganization |
gptkb:European_Medicines_Agency
|
| gptkbp:partOf |
gptkb:European_Medicines_Agency
|
| gptkbp:predecessor |
gptkb:Committee_for_Proprietary_Medicinal_Products
|
| gptkbp:responsibleFor |
scientific evaluation of medicines for human use
|
| gptkbp:reviewedBy |
marketing authorization applications
|
| gptkbp:type |
scientific committee
|
| gptkbp:website |
https://www.ema.europa.eu/en/committees/chmp
|
| gptkbp:bfsParent |
gptkb:European_Medicines_Agency
gptkb:EMA |
| gptkbp:bfsLayer |
5
|